Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2023 Filed May 18, 2023 22:20 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 63,567 | $1.07 | $67,889.56 |
DisclosureSEC source: 0001562180-23-004254 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 530,487 F1 · shares: This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on May 12, 2022. Read SEC document |
| May 16, 2023 Filed May 18, 2023 22:19 UTC |
Spellman David ASVP, CFO and Treasurer
|
SaleCommon Stock | 63,567 | $1.07 | $67,889.56 |
DisclosureSEC source: 0001562180-23-004253 · primarydocument.xml · nonDerivative · entry 1 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,483 F1 · shares: This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on June 8, 2022. Read SEC document |
| May 12, 2023 Filed May 16, 2023 16:09 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004168 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,515 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:10 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004169 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 387,530 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 08:01 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 1,878 | $0.88 | $1,647.95 |
DisclosureSEC source: 0001562180-23-002198 · primarydocument.xml · nonDerivative · entry 3 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,515 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 08:01 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 10,476 | $0.88 | $9,192.69 |
DisclosureSEC source: 0001562180-23-002198 · primarydocument.xml · nonDerivative · entry 2 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,393 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 08:01 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 8,058 | $0.88 | $7,070.90 |
DisclosureSEC source: 0001562180-23-002198 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,869 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 6,370 | $0.88 | $5,589.68 |
DisclosureSEC source: 0001562180-23-002201 · primarydocument.xml · nonDerivative · entry 3 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568,872 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 47,239 | $0.88 | $41,452.22 |
DisclosureSEC source: 0001562180-23-002201 · primarydocument.xml · nonDerivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575,242 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 38,259 | $0.88 | $33,572.27 |
DisclosureSEC source: 0001562180-23-002201 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622,481 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 1,088 | $0.88 | $954.72 |
DisclosureSEC source: 0001562180-23-002200 · primarydocument.xml · nonDerivative · entry 3 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,530 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 6,613 | $0.88 | $5,802.91 |
DisclosureSEC source: 0001562180-23-002200 · primarydocument.xml · nonDerivative · entry 2 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,618 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 5,333 | $0.88 | $4,679.71 |
DisclosureSEC source: 0001562180-23-002200 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,231 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 1,110 | $0.88 | $974.03 |
DisclosureSEC source: 0001562180-23-002199 · primarydocument.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,054 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 6,400 | $0.88 | $5,616.00 |
DisclosureSEC source: 0001562180-23-002199 · primarydocument.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 595,164 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 6,613 | $0.88 | $5,802.91 |
DisclosureSEC source: 0001562180-23-002199 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,564 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:00 UTC |
Spellman David ASVP, CFO and Treasurer
|
SaleCommon Stock | 810 | $0.88 | $710.78 |
DisclosureSEC source: 0001562180-23-002197 · primarydocument.xml · nonDerivative · entry 2 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,050 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:00 UTC |
Spellman David ASVP, CFO and Treasurer
|
SaleCommon Stock | 6,400 | $0.88 | $5,616.00 |
DisclosureSEC source: 0001562180-23-002197 · primarydocument.xml · nonDerivative · entry 1 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,860 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 16:06 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 10,090 | $0.81 | $8,205.19 |
DisclosureSEC source: 0001562180-23-002039 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,927 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. F2 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on June 30, 2022, and 1,500 shares of the Issuers common stock purchased on December 30, 2022, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:07 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 38,632 | $0.81 | $31,415.54 |
DisclosureSEC source: 0001562180-23-002041 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,660,740 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:06 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 7,539 | $0.81 | $6,130.71 |
DisclosureSEC source: 0001562180-23-002040 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,177 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:05 UTC |
Spellman David ASVP, CFO and Treasurer
|
SaleCommon Stock | 7,539 | $0.81 | $6,130.71 |
DisclosureSEC source: 0001562180-23-002038 · primarydocument.xml · nonDerivative · entry 1 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,260 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:05 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 6,677 | $0.81 | $5,429.74 |
DisclosureSEC source: 0001562180-23-002037 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,564 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. F2 · balance_after: Includes 1,500 shares of the Issuers common stock purchased on June 30, 2022, and 1,500 shares of the Issuers common stock purchased on December 30, 2022, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:15 UTC |
Butler John P.Director · CEO and President
|
GrantStock Option (Right to buy) · Derivative | 875,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001562180-23-000832 · primarydocument.xml · derivative · entry 7 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875,000 Underlying: Common Stock · 875,000 shares Expires 2033-01-31 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:15 UTC |
Butler John P.Director · CEO and President
|
GrantStock Appreciation Right · Derivative | 635,313 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001562180-23-000832 · primarydocument.xml · derivative · entry 6 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,313 Underlying: Common Stock · 635,313 shares Expires 2033-01-31 F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The SARs will vest over four years: 25% of the SARs will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:15 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 293,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000832 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,699,372 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022 and 1,500 shares of the Issuer's common stock purchased on December 30, 2022, each under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:14 UTC |
Spellman David ASVP, CFO and Treasurer
|
GrantStock Option (Right to buy) · Derivative | 294,300 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001562180-23-000831 · primarydocument.xml · derivative · entry 2 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,300 Underlying: Common Stock · 294,300 shares Expires 2033-01-31 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:14 UTC |
Spellman David ASVP, CFO and Treasurer
|
GrantCommon Stock | 196,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000831 · primarydocument.xml · nonDerivative · entry 1 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,799 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:14 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 294,300 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001562180-23-000830 · primarydocument.xml · derivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,300 Underlying: Common Stock · 294,300 shares Expires 2033-01-31 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:14 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 196,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000830 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615,716 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on December 30, 2022 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 20:15 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 1,147 | $0.36 | $415.79 |
DisclosureSEC source: 0001562180-22-006402 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,016 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022, under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 21:00 UTC |
Wolf MylesDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004978 · primarydocument.xml · derivative · entry 2 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 21:00 UTC |
Wolf MylesDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004978 · primarydocument.xml · nonDerivative · entry 1 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,681 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:56 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004973 · primarydocument.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:56 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004973 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,800 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:58 UTC |
ROGERS MICHAEL WDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004976 · primarydocument.xml · derivative · entry 2 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:58 UTC |
ROGERS MICHAEL WDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004976 · primarydocument.xml · nonDerivative · entry 1 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,029 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 21:01 UTC |
ZUMWALT LEANNE MDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004980 · primarydocument.xml · derivative · entry 2 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 21:01 UTC |
ZUMWALT LEANNE MDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004980 · primarydocument.xml · nonDerivative · entry 1 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 16:58 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004975 · primarydocument.xml · derivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 16:58 UTC |
GILMAN STEVEN CDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004975 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,130 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:59 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004977 · primarydocument.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:59 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004977 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,233 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:57 UTC |
FRIESON RONDirector
|
GrantStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-004974 · primarydocument.xml · derivative · entry 2 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 F2 · shares: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:57 UTC |
FRIESON RONDirector
|
GrantCommon Stock | 13,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004974 · primarydocument.xml · nonDerivative · entry 1 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 12:11 UTC |
Spellman David ASVP, CFO and Treasurer
|
GrantStock Option (Right to buy) · Derivative | 200,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-22-005001 · primarydocument.xml · derivative · entry 2 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-06-08 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock ("the Stock Option") was granted by the Issuer pursuant to the 2014 Plan. The Stock Option will vest and become exercisable in full (100%) on May 12, 2023, subject to the Reporting Person's continued service with the Issuer on such vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 12:11 UTC |
Spellman David ASVP, CFO and Treasurer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005001 · primarydocument.xml · nonDerivative · entry 1 Spellman David A · CIK 0001733204 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,599 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"). The RSUs will vest in full (100%) on May 12, 2023, subject to the Reporting Person's continued service with the Issuer on such vesting date. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 16:03 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 4,567 | $0.36 | $1,653.25 |
DisclosureSEC source: 0001562180-22-004870 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,430 F1 · kind: This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 2, 2021. Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:08 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 200,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001562180-22-004031 · primarydocument.xml · derivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-05-12 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date. Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:08 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004031 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,663 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.